ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

NCT00386997 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Study closed due to recruitment challenges.

Conditions

Fungal Infection

Interventions

DRUG: liposomal amphotericin B (AmBisome®)

Sponsor

Gilead Sciences